Article
Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Feb 2007
Sungkanuparph Somnuek, Manosuthi Weerawat, Kiertiburanakul Sasisopin, Piyavong Bucha, Chumpathat Noppanath, Chantratita Wasun
Abstract excerpt
BACKGROUND: A fixed-dose combination of stavudine, lamivudine, and nevirapine is extensively used as an antiretroviral regimen in developing countries because of its affordability. Virological failure with this regimen has become more common, and a second-line regimen needs to be prepared in the national program. METHODS: Genotypic resistance testing was conducted among human immunodeficiency virus type 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.